Longitudinal Assessment of Body Composition and Inflammatory Status in Rheumatoid Arthritis During TNF Inhibitor Treatment: A Pilot Study
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26157635 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Natalia Mena-Vázquez und 10 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29590 Málaga, Spain. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Body Composition, Tumor Necrosis Factor Inhibitors, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Instituto Salud Carlos III, Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), Red de Enfermedades Inflamatorias (REI).
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a chronic inflammatory disease frequently associated with alterations in body composition, including reduced lean mass and increased fat mass. These alterations are thought to be driven by persistent systemic inflammation, which may be influenced by inflammatory activity and by therapeutic interventions. Objectives: This pilot study aimed to provide preliminary data on changes in body composition and inflammatory activity in biologic-naive patients with active RA during the initial 6 months of TNF inhibitor treatment, and to compare baseline body composition with healthy controls. We conducted a single-center, observational, 24-week pilot study of 70 biologic-naive RA patients with moderate-to-severe disease activity and 70 matched healthy controls. Lean mass, fat mass, and lean mass index (LMI) were measured using dual-energy X-ray absorptiometry at baseline for both groups, and after 6 months only in the RA group. Clinical, laboratory, adipokines, and cytokine parameters were also recorded. At baseline, RA patients had lower lean mass and LMI than controls. Over 6 months, RA patients showed significant clinical and laboratory improvement, with a corresponding increase in lean mass and LMI. No statistically significant change was observed in fat mass. The increase in lean mass was paralleled by a reduction in inflammatory markers. The LMI was inversely associated with female sex (β = −0.562) and C-reactive protein (β = −0.432) and directly associated with body mass index (β = 0.570). Similar associations were observed for total lean mass and change in lean mass, as well as for DAS28 (β = −0.333). This pilot study provides preliminary evidence that TNF inhibitor therapy may be associated with increased lean mass and decreased inflammation in RA patients. Owing to the absence of a comparator RA group not receiving TNF inhibitors, these findings should be interpreted as hypothesis-generating.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29590 Málaga, Spain.
- UGC de Reumatología, Hospital Regional Universitario de Málaga, 29009 Málaga, Spain.
- Departamento de Medicina, Universidad de Málaga, 29071 Málaga, Spain.
- Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Clínico Virgen de la Victoria, 29010 Málaga, Spain.
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.
ORCID-Profile: Natalia Mena-Vázquez, Fernando Ortiz-Márquez, Sara Manrique-Arija, Arkaitz Mucientes, Jose Manuel Lisbona-Montañez, Patricia Ruiz-Limón, Antonio Fernández-Nebro
Förderung
- Instituto de Salud Carlos III
- Instituto Salud Carlos III
- Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), Red de Enfermedades Inflamatorias (REI)
- ISCIII-Madrid (Spain)
- European Union
Zitieren
APA
Mena-Vázquez, N., García-Studer, A., Ortiz-Márquez, F., Manrique-Arija, S., Mucientes, A., Lisbona-Montañez, J. M., Borregón-Garrido, P., Ruiz-Limón, P., Redondo-Rodriguez, R., Cano-García, L., & Fernández-Nebro, A. (2025). Longitudinal Assessment of Body Composition and Inflammatory Status in Rheumatoid Arthritis During TNF Inhibitor Treatment: A Pilot Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157635
Vancouver
Mena-Vázquez N, García-Studer A, Ortiz-Márquez F, Manrique-Arija S, Mucientes A, Lisbona-Montañez JM, et al. Longitudinal Assessment of Body Composition and Inflammatory Status in Rheumatoid Arthritis During TNF Inhibitor Treatment: A Pilot Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157635
BibTeX
@article{MenaVzquez2025,
author = {Mena-Vázquez, Natalia and García-Studer, Aimara and Ortiz-Márquez, Fernando and Manrique-Arija, Sara and Mucientes, Arkaitz and Lisbona-Montañez, Jose Manuel and Borregón-Garrido, Paula and Ruiz-Limón, Patricia and Redondo-Rodriguez, Rocío and Cano-García, Laura and Fernández-Nebro, Antonio},
title = {Longitudinal Assessment of Body Composition and Inflammatory Status in Rheumatoid Arthritis During TNF Inhibitor Treatment: A Pilot Study},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26157635}
}
EUVIMED